UCLA study: Nearly a third of drug ads in medical journals contain no references for medi...( UCLA investigators reviewed pharmaceuti...),Health

UCLA investigators reviewed pharmaceutical ads in American medical journals and found that nearly one-third contained no references for medical claims; while the majority of references to published material were available, only a minority of company data-on-file documents were provided upon request; and the majority of original research cited in the ads was funded by or had authors affiliated with the product's manufacturer.

In one of the largest studies of its kind, UCLA investigators reviewed pharmaceutical ads in American medical journals to determine what materials are cited in support of medical claims and if those references are available to physicians. Researchers also determined the funding sources of research cited in the ads. The study is published in the Feb. 15 issue of the Canadian Medical Association Journal.

"Previous studies have shown that physicians' drug prescribing is influenced by pharmaceutical ads. We wanted to see what documents were being used to substantiate the claims and how accessible these were to physicians who may want to verify the research findings," said lead author Dr. Richelle Cooper, assistant clinical professor, Division of Emergency Medicine, David Geffen School of Medicine at UCLA.

Two UCLA investigators independently reviewed 438 ads from 10 American medical journals from 1999 and also reviewed a random sample of 400 references in journal articles from the same publications for comparison.

Researchers found that out of 438 pharmaceutical ads, 126 or 29 percent, offered no references in support of medical claims. The most commonly cited references in the ads included journal articles (55 percent) and data-on-file (19 percent), which is a reference to an unpublished company document. Other sources included books; prescribing information such as the Physician's Desk Reference -- which annually provides information on drug usage, warnings and drug interactions; government documents; o
'"/>

Contact: Rachel Champeau
rchampeau@mednet.ucla.edu
310-794-0777
University of California - Los Angeles
14-Feb-2005

Page: 1 2 3
Related medicine news :

1. UNC study: Most N.C. family practitioners engage in unrecognized community service
2. More homeless mentally ill than expected according to UCSD study: Interventions urged
3. Lab study: Protein delivered via genetically engineered virus slowed glioblasoma multiforme growth
4. Mouse study: Signal overload in Alzheimer brains
5. OHSU study: Testosterone deprivation makes men forget
6. Mayo Clinic led study: Minimally invasive surgery safe, effective for patients with colon cancer
7. New study: Small, frequent doses of caffeine best strategy for staying awake
8. OHSU study: Rate of brain volume loss predicts dementia
9. Major study: Bioartificial liver reduces mortality by 44 percent in acute liver-failure patients
10. National study: Health care access for poor children improves, but gap in care for uninsured grows
11. UCSF study: Pediatricians judgment often better than clinical guidelines for treating infant fever